首頁 > 市場調查報告書 > 醫療設備

拋棄式

市場調查報告書

商品編碼

1654729

英國外科手術用墊片市場 - 2025 至 2033 年

U.K. Surgical Pledgets Market - 2025-2033

出版日期: 2025年02月13日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年英國手術棉片市場規模達到 1,350 萬美元，預計到 2033 年將達到 2,090 萬美元，在 2025-2033 年預測期內的複合年成長率為 5.4%。

手術縫合墊是外科手術過程中用來提高縫合效果的專用醫療設備。它們是不可吸收的合成貼片，主要由聚四氟乙烯 (PTFE) 製成。這些貼片通常很小、很扁平、很有彈性，設計用於在手術過程中放置在縫線下方。

手術墊的主要用途是作為縫合線支撐。當縫合線應用於脆弱的組織時，縫合線施加的張力可能會導致周圍組織撕裂或受損。縫合線透過將縫合線的張力分散到更大的區域來幫助減輕這種風險。這種更廣泛的分佈減少了組織上的局部壓力，從而保護其免受拉傷和潛在傷害。這些因素推動了英國手術用棉片市場的擴張。

市場動態：

促進因素與約束因素

外科技術的進步

手術技術的進步是英國手術棉片市場成長的關鍵驅動力，顯著提高了手術棉片的有效性、安全性和應用性。材料科學的最新創新導致了用於手術墊的先進合成材料的開發，例如聚四氟乙烯（PTFE）和其他生物相容性聚合物。這些材料表現出低組織反應性和高耐久性，使其成為外科手術應用的理想選擇。

現代手術環境擴大採用機器人輔助手術和增強成像系統等技術。手術敷料被設計成與這些系統無縫整合，從而實現更精確的放置和更好的結果。這種技術整合提高了手術過程的整體效果。所有這些因素都對英國手術用棉片市場提出了要求。此外，對微創手術的需求不斷成長，促進了英國手術棉片市場的擴張。

手術墊料成本高昂

手術棉片的高成本是英國手術棉片市場的重大限制因素，對醫療保健提供者和患者都產生影響。手術用棉條的價格昂貴，這對醫院和外科中心來說是一個財務挑戰，特別是那些預算有限的醫院和外科中心。當面臨高昂成本時，這些機構可能會優先考慮基本醫療用品，而不是諸如棉墊之類的專用物品，這可能會影響手術期間這些物品的可用性。

費用上漲可能會限制患者接受必要的手術。如果醫療機構無法負擔這些費用，他們可能會將其轉嫁給患者，從而降低手術費用。這種經濟障礙可能會阻止患者及時尋求手術干預，導致治療延誤和健康惡化。

手術縫合墊的高成本可能導致醫療保健提供者考慮其他傷口閉合方法，例如手術縫合器或膠帶，這些方法被認為是更具成本效益的選擇。由於供應商選擇更適合其預算限制的替代品，這種偏好的轉變可能會阻礙手術棉片市場的成長。因此，上述因素可能會限制英國手術棉片市場的潛在成長。

Surgical pledgets are specialized medical devices utilized in surgical procedures to improve the effectiveness of sutures. They are non-absorbable synthetic patches primarily constructed from polytetrafluoroethylene (PTFE). These patches are typically small, flat, and resilient and are designed to be placed beneath sutures during surgical interventions.

The main purpose of surgical pledgets is to serve as suture supports. When sutures are applied to delicate tissues, there is a risk that the tension exerted by the sutures may cause tearing or damage to the surrounding tissue. Pledgets help alleviate this risk by distributing the tension of the sutures over a wider area. This broader distribution reduces localized pressure on the tissue, thereby protecting it from strain and potential injury. These factors have driven the U.K. surgical pledgets market expansion.

Market Dynamics: Drivers & Restraints

Advancements in Surgical Technologies

Advancements in surgical technologies are a crucial driver of growth in the U.K. surgical pledgets market, significantly enhancing their effectiveness, safety, and application. Recent innovations in materials science have led to the development of advanced synthetic materials for surgical pledgets, such as polytetrafluoroethylene (PTFE) and other biocompatible polymers. These materials exhibit low tissue reactivity and high durability, making them ideal for surgical applications.

Modern surgical environments are increasingly incorporating technologies such as robotic-assisted surgery and enhanced imaging systems. Surgical pledgets are being designed to integrate seamlessly with these systems, allowing for more precise placement and improved outcomes. This technological integration enhances the overall efficacy of surgical procedures. All these factors demand the U.K. surgical pledgets market. Moreover, the growing demand for minimally invasive surgeries contributes to the U.K. surgical pledgets market expansion.

High Cost of Surgical Pledgets

The high cost of surgical pledgets is a significant constraint in the U.K. surgical pledgets market, impacting both healthcare providers and patients. The substantial price of surgical pledgets presents a financial challenge for hospitals and surgical centers, especially those operating with limited budgets. When confronted with high costs, these facilities may prioritize essential medical supplies over specialized items like pledgets, potentially affecting their availability during surgeries.

Elevated costs can restrict patient access to necessary surgical procedures. If healthcare facilities are unable to absorb these expenses, they may pass them on to patients, making surgeries less affordable. This financial barrier can deter patients from seeking timely surgical interventions, leading to delays in treatment and worsening health outcomes.

The high cost of surgical pledgets may lead healthcare providers to consider alternative wound closure methods, such as surgical staplers or adhesive strips, which are perceived as more cost-effective options. This shift in preference could hinder the growth of the surgical pledgets market as providers opt for alternatives that better fit their budget constraints. Thus, the above factors could be limiting the U.K. surgical pledgets market's potential growth.

Segment Analysis

The U.K. surgical pledgets market is segmented based on type, material, application, end-user, and region.

Type:

The non-absorbable pledgets segment is expected to dominate the U.K. surgical pledgets market share

The non-absorbable pledgets segment holds a major portion of the U.K. surgical pledgets market share and is expected to continue to hold a significant portion of the U.K. surgical pledgets market share during the forecast period.

Non-absorbable pledgets are synthetic devices specifically designed to provide reinforcement and support to sutured tissues during surgical procedures. They are primarily made from materials such as Polytetrafluoroethylene (PTFE) known for their exceptional durability, low friction, and minimal tissue reactivity, making them suitable for long-term applications. Polyester is valued for its strength and compatibility with various surgical techniques. These materials are selected for their ability to withstand biological environments without degrading, ensuring their effectiveness throughout the healing process.

Non-absorbable pledgets hold a significant share of the U.K. surgical pledgets market due to their widespread adoption across various surgical specialties. Their durability and low risk of complications contribute to their popularity among healthcare providers.

Non-absorbable pledgets are utilized in several key areas of cardiac surgery they provide essential support during procedures such as aortic valve replacements and coronary artery bypass grafts, where maintaining suture integrity is critical. Thoracic surgery is used to reinforce sutures in lung surgeries, ensuring stability and minimizing complications. General surgery is employed in diverse surgical procedures to enhance suture performance and reduce tissue damage.

The increasing prevalence of cardiovascular diseases among the aging population in the U.K. is driving demand for non-absorbable pledgets. As the geriatric demographic expands, so does the need for surgical interventions that utilize these devices. Innovations in material science are leading to the development of more effective non-absorbable pledget designs, enhancing their performance and broadening their applications across different surgical specialties. These factors have solidified the segment's position in the U.K. surgical pledgets market.

Competitive Landscape

The major players in the U.S. pollinosis market include Medtronic, B. Braun SE, Johnson & Johnson (Ethicon), Teleflex Incorporated., PetersSurgical, DeRoyal Industries, Inc., BD, Boz Medical, Advanced MedTech Solutions Pvt. Ltd, and Golnit among others.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The U.K. surgical pledgets market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Material
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Advancements in Surgical Technologies
- 4.1.2. Restraints
  - 4.1.2.1. High Cost of Surgical Pledgets
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Type

6.1. Introduction
- 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
- 6.1.2. Market Attractiveness Index, By Type
6.2. Non-Absorbable Pledgets*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Absorbable Pledgets

7. By Material

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 7.1.2. Market Attractiveness Index, By Material
7.2. Polytetrafluoroethylene (PTFE)*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Polypropylene
7.4. Dacron
7.5. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Cardiac Surgery*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Thoracic Surgery
8.4. General Surgery
8.5. Others

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Clinics
9.4. Ambulatory Surgical Centers (ASCs)
9.5. Others

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Medtronic *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio
  - 11.1.2.1. Product Description
  - 11.1.2.2. Product Key Performance Indicators (KPIs)
  - 11.1.2.3. Historic and Forecasted Product Sales
  - 11.1.2.4. Product Sales Volume
- 11.1.3. Financial Overview
  - 11.1.3.1. Company Revenue's
  - 11.1.3.2. Geographical Revenue Shares
  - 11.1.3.3. Revenue Forecasts
- 11.1.4. Key Developments
  - 11.1.4.1. Mergers & Acquisitions
  - 11.1.4.2. Key Product Development Activities
  - 11.1.4.3. Regulatory Approvals etc.
- 11.1.5. SWOT Analysis
11.2. B. Braun SE
11.3. Johnson & Johnson (Ethicon)
11.4. Teleflex Incorporated.
11.5. PetersSurgical
11.6. DeRoyal Industries, Inc.
11.7. BD
11.8. Boz Medical
11.9. Advanced MedTech Solutions Pvt. Ltd
11.10. Golnit